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Abstract
Background The highly polymorphic nonclassical MHC
class I chain-related genes A and B (MICA and MICB)
encode stress-inducible glycoproteins expressed on various
epithelial cells including intestinal epithelial cells. MICA
and MICB gene polymorphisms and expressions are
associated with autoimmune diseases but not known in
ulcerative colitis (UC).
Aims To investigate the association of MICB exon 2-4
polymorphisms and soluble MICA (sMICA) expression
with the susceptibility of UC in central China.
Materials and methods Genomic DNA was isolated from
peripheral blood. The allele frequencies of MICB exon 2-4
were genotyped in 105 UC patients and 213 healthy controls
by PCR single-stranded conformation polymorphismmethod.
Thirty-two patients and 32 controls were selected for
determining serum sMICA expression by ELISA.
Results Allele frequency of MICB0106 was significantly
higher in UC patients than in healthy controls (19.0% vs.
8.9%, corrected P (Pc)=0.0006), especially in patients with
extensive colitis (24.4% vs. 8.9%, Pc=0.0006), moderate
and severe disease (24.1% vs. 8.9%, Pc=0.0006), extra-
intestinal manifestations (20.5% vs. 8.9%, Pc=0.012), male
patients (22.1% vs. 8.0%, Pc=0.006), and patients over the
age of 40 years (28.8% vs. 8.3%, Pc=0.0006). The sMICA
level was significantly higher in UC than in healthy controls
(604.41±480.43 pg/ml vs. 175.37±28.31 pg/ml, P=0.0001)
but not associated with the MICB0106 genotypes.
Conclusions Overall, MICB0106 allele was positively
associated with UC in the Han Chinese in central China.
sMICAwas highly expressed in UC but not associated with
the MICB0106 genotype.
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Introduction
Ulcerative colitis (UC) is a subtype of chronic nonspecific
inflammatory bowel disease (IBD) with unknown etiology.
Epidemiological studies in the European and American
countries have demonstrated strong evidences of genetic
susceptibility to IBD, such as concordance rates in twins
and multiply-affected families [1, 2]. Moreover, several
genetic studies have found that the HLA genes, which are
located on chromosome 6p (IBD3), is one group of the
susceptible loci of UC [3, 4]. Therefore, major histocom-
patibility complex (MHC) genes have been studied as
candidate genes for the susceptibility of UC.
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The MHC class I chain-related (MIC) gene is located 47-
kilo base pairs (kb) centromeric to HLA-B [5]. Mapping
studies identified seven MIC loci (MICA–MICG), of which
only MICA and MICB encode transcripts, while MICC,
MICD, MICE, MICF, and MICG are pseudogenes. MIC
molecules show homology with classical HLA molecules but
do not combine with β2 microglobulin or recognize antigen.
The MIC molecules have three external domains (α1–3), one
transmembrane, and one cytoplasmic domain. The highly
polymorphic MICA and MICB encode stress-inducible
glycoproteins expressed on a variety of epithelial cells
including intestinal epithelial cells. Interaction with the
receptor NKG2D is likely to provide an important costimu-
latory signal for the activation of natural killer (NK) cells,
macrophages, CD8+αβ, and gδT cells [6].
There are 65 recognized human MICA alleles and 30
different MICB alleles which have been identified so far
(http://www.ebi.ac.uk/imgt/hla) [7]. The microsatellite poly-
morphism in exon 5 of MICA gene consists of five alleles
based on the number of GCT/AGC triplet repeat units
(alleles A4, A5, A6, and A9) and the presence of an
additional nucleotide G/C insertion (allele A5.1) [8]. MICB
is the closest neighbor related to MICA, which has strict
polymorphism. The (CA/TG)n microsatellite, consisting of
15 alleles, is present in intron 1 of theMICB gene (CA14-28)
[9]. However, numerous high polymorphisms are more likely
within the extracellular domain encoding exons 2, 3, and 4
of MICB. Recently, MICA and MICB gene polymorphisms
have been found associated with autoimmune diseases [10]
including insulin-dependent diabetes mellitus [11], Addison's
disease [12, 13], celiac disease [14, 15], rheumatoid arthritis
[16, 17], Behcet's disease [18, 19], and IBD [20–23],
although little is known about the association between exons
2, 3, and 4 of MICB gene polymorphisms and UC.
In our previous studies, we found ethnic differences in
the distribution of MICA (exon 5) and MICB (intron 1)
gene polymorphisms [24–28] in central China. MICA-
A5.1/A5.1 homozygous genotype, MICA-A5.1 [27], and
MICB-CA18 [28] allele are associated with UC in Chinese
patients. Since MICA and MICB play important roles in
immune regulation in autoimmune diseases and very few
studies have observed an association of MICB polymor-
phism with the hereditary susceptibility to UC, therefore,
we provided the exon 2-4 of MICB gene polymorphism
and the soluble MICA (sMICA) expression for the
susceptibility to UC in the Chinese Han population.
Materials and methods
Patients and healthy controls
A total of 105 UC patients with no family history who
registered at our hospital from 2002 to 2006, were
randomly collected and investigated. The diagnosis of UC
was based on conventional clinical, endoscopic, and
pathohistological criteria as described by Lennard-Jones
[29]. Using the Montreal classification [30], the extent of
the disease was classified as extensive colitis (involvement
extends proximal to the splenic flexure) and left side colitis
(involvement limited to a proportion of the colorectum
distal to the splenic flexure) on endoscopy examination.
The severity of UC was defined as mild, moderate, and
severe colitis. We combined moderate and severe colitis
since there were only five patients in the severe group.
Extraintestinal manifestations (EIMs) of patients, including
abnormal manifestations on joint, skin, eyes, and primary
sclerosing cholangitis, were reviewed by records of the case
history and interviews with the patients. A group of 213
unrelated ethnically matched blood donors who matched
with gender and age were selected as healthy controls (HC).
All the patients and controls were unrelated Chinese with
Han nationality. The study was approved by the ethics
committee of Wuhan University Zhongnan Hospital, and all
the subjects gave informed consent.
DNA isolation
Genomic DNA was isolated from EDTA anti-coagulated
peripheral venous blood by a conventional proteinase K
digestion/phenol–chloroform extraction method.
Allele genotyping for exon 2, 3, and 4 of MICB
MICB alleles were determined by polymerase chain
reaction (PCR) amplification on exons 2, 3, and 4 and
followed by single-stranded conformation polymorphism
(SSCP) analysis. The primers and annealing temperatures
were forward 5′-CCAGGAAGAAGTTTCACCTG-3′,
reward 5′-CTGCTCTCTGTCTCCAACTT-3′, 54°C; for-
ward 5′-AAGGTGATGGGTTCGGGAAT-3′, reward
5 ′ -AGCAGAATTGCGGGAACAGT- 3 ′ , 5 6 °C ;
forward 5′-GTGAGAACAGTGGAGAGGAG-3′, reward
5′-CACAGCCGTCCCTGCTGTT-3′, 58°C, respectively,
for amplifying exon 2, 3, and 4, which were designed
using the genomic DNA sequence of MICB [31]. The
concentration of primers used was 0.4 mM. PCR amplifi-
cation was carried out in a 30-μL volume containing
100 ng of genomic DNA, 2.5 mM of MgCl2, 3 μL
10×GeneAmp PCR Buffer II, 200 μM of each dNTP, and
0.5 units of AmpliTaq Gold DNA Polymerase (PE
Biosystems). The PCR conditions (in BIO-RAD PCR
apparatus) were as follows: heating at 95°C for 5 min,
followed by 30 cycles of denaturation at 95°C for 30 s,
annealing temperature for 45 s, extension at 72°C for 45 s,
and a final extension at 72°C for 10 min. The amplified
DNA fragments were analyzed by a previously described
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modified PCR–SSCP method [32]. Exons 2–4 were applied
to an 8% polyacrylamide gel (without glycerol) and carried
on electrophoresis at 200 V for 2 h. Denatured single-
stranded DNA fragments separated in the gel were
visualized by silver staining. Genomic DNAs from HLA
homozygous typing cell lines with MICB alleles were used
as standards [33].
MICB alleles were assigned based on the distinct and
combined SSCP patterns of exons 2, 3, 4, respectively
(Fig. 1a–c). PCR products were directly sequenced as
proved by an automated DNA sequencer (ABI PRISM
3730, BigDye terminator v3.1 reagent) using the same
primers.
sMICA analysis
cMICA in serum was tested by sandwich enzyme-
linked immunosorbent assay (ELISA) [34]. The ELISA
development kit contains the basic components required,
including capture antibody, detection antibody, standard,
and Streptavidin-HRP (R&D Systems, USA). After being
tested in microplate reader (Tecan, Australia) set at
450 nm, we constructed a standard curve by plotting the
mean absorbance for each standard on the Y axis against
the concentration on the X axis, calculated as
lg Y ¼ 2:24555þ 0:66933 lg X. The data were fitted
by plotting the log of the MICA levels (picograms per
milliliter) versus the log of the O.D based on linear
regression analysis.
Statistical analysis
SPSS 11.5 was used for statistical calculations. The allelic
frequencies were calculated by direct counting, and
statistical comparisons were performed by the χ2 test with
Fisher's exact test. sMICA levels were analyzed by
independent samples nonparametric test. Odds ratios (OR)
and 95% confidence intervals (CI) were calculated for the
carriers of the specific genotype. Bonferroni multiple
corrections were used for the corrected P (Pc) by
multiplying the P value by the number of the statistical
tests in order to avoid the α1 error. The P and Pc below
0.05 were considered to be statistically significant.
Results
Baseline characteristics of UC patients
The demographic characteristics and clinical features of the
patients are shown in Table 1.
No significant differences were found in gender and
mean age of UC patients and controls (all P>0.05). In these
105 patients, the mean duration of UC was (3.5±1.4) years.
There were 41 (39.0%) patients with extensive colitis and
64 (61.0%) patients with left side colitis; 44 (41.9%)
patients had extraintestinal manifestation; 58 (55.2%)
patients suffered from with moderate or severe disease.
Only one (1.0%) patient had colostomy.
The distribution of MICB alleles between UC patients
and healthy controls
The distribution of MICB alleles in 105 UC patients and
213 HC is shown in Table 2.
The frequency of MICB0106 was significantly higher in
UC patients (40/210) than in the healthy controls (38/426;
19.0% vs. 8.9%; P=0.0001; Pc=0.0006; OR=2.402; 95%
CI, 1.488–3.879). Other differences between UC patients
and healthy controls did not reach statistical significance.
The associations between the distribution of MICB alleles
and clinical phenomenon of UC patients
When analyzing the distribution of MICB alleles in the
subgroup of UC according to disease extent, severity,
EIMs, and patients' gender and age, our study only showed
that the frequency of MICB0106 was significantly higher in
patients with extensive colitis (20/82) than in those with left
side colitis (20/128; 24.4% vs. 8.9%; P=0.0001; Pc=
0.0006; OR=3.294; 95%CI, 1.800–6.027); higher in mod-
erate and severe disease (28/116) than in mild disease (12/
94; 24.1% vs. 8.9%; P=0.0001; Pc=0.0006; OR=3.249;
95%CI, 1.893–5.576); and higher in those with EIMs (18/
88) than in non-EIMs (22/122; 20.5% vs. 8.9%; P=0.002;
Pc=0.012; OR=2.626; 95%CI, 1.418–4.861). Furthermore,
the frequency of MICB0106 allele was significantly higher
in the male patients (27/122; 22.1% vs. 8.0%; P=0.001;
Pc=0.006; OR=3.276; 95%CI, 1.737–6.178) and in those
patients over the age of 40 years (34/118; 28.8% vs. 8.3%;
Fig. 1 PCR-SSCP analysis of MICB allele. a Three distinct banding
patterns were observed in exon 2. b Four distinct banding patterns
were observed in exon 3. c Only two distinct banding patterns were
observed in exon 4. Banding patterns with one or two lanes showed
homozygosis, while three or four lanes showed heterozygosis
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P=0.0001; Pc=0.0006; OR=4.500; 95%CI, 2.381–8.504)
compared with healthy controls (13/88 and 17/206, respec-
tively). Therefore, MICB0106 allele was associated with
extensive colitis, moderate and severe disease, EIMs, male
UC patients, and the patients over the age of 40 years.
The difference in MICB distributions between China
and western countries
To determine the effect of ethnicity on MICB gene
polymorphism and even its susceptibility to UC, we also
investigated the differences in MICB distributions between
China (our study) and western countries [22, 35] (Table 3).
There were significant differences in MICB distribution
between the Chinese and English (P=0.0001) and between
the Chinese and the Spanish (P=0.018).
sMICA expression in UC patients and healthy controls
In order to investigate sMICA, we selected 33 UC
patients and 32 healthy controls randomly from the
subjects we had previously. The patients were divided
into three subgroups: (1) 12 UC patients carried
MICB0106; (2) Eight UC patients carried MICA-A5.1;
(3) 13 UC patients carried neither MICB0106 nor
MICA-A5.1. Those who carried both MICB0106 and
MICA-A5.1 were not included. Tested by a sandwich
ELISA, the mean sMICA concentration in the serum of
33 UC patients (604.41±480.43 pg/ml) was 3∼6-fold
higher than that in 32 healthy control (175.37±
28.31 pg/ml; Fig. 2a). The significant difference reached
Z=-6.967, P=0.0001, which indicates that sMICA was
strongly associated with UC.
The correlation between sMICA expression and MICB
gene polymorphism
To correlate sMICA expression to MICB gene polymor-
phism, we compared the three intersubgroups of UC. The
sMICA concentration in both subgroups of MICB0106
carriers and MICA-A5.1 carriers were higher than those in
non-MICB0106/MICA-A5.1 carriers (647.64±518.07 pg/
ml vs. 543.32±343.70 pg/ml; 641.76±603.73 pg/ml vs.
543.32±343.70 pg/ml), but the differences between sMICA
levels among them did not reach statistical significance
(P ¼ 0:487 > 0:05) (Fig. 2b).
UC (n=105) HC (n=213)
Gender (%)
Male 61 (58.1%) 119 (55.9%)
Female 44 (41.9%) 94 (44.1%)
Mean age of diagnosis (range, in years) 46.95±14.01 (16–79) 41.97±14.81 (21–77)
Mean course of disease (years) 3.5±1.4 (1–18)
Extent of disease (%)
Extensive colitis 41 (39.0%)
Left side colitis 64 (61.0%)
Extraintestinal manifestations (%)
Yes 44 (41.9%)
No 61 (58.1%)
Severity of disease (%)
Mild 47 (44.8%)
Moderate and severe 58 (55.2%)
Colostomy (%) 1 (1.0%)
Table 1 Demographic charac-
teristics and clinical features of
the patients with UC and healthy
controls
MICB allele UC (2n=210; %) HC (2n=426; %) χ2 P Pc
0102 86 (41.0) 189 (44.4) 0.668 0.414 2.484
0103 28 (13.3) 53 (12.4) 0.101 0.751 4.506
0104 32 (15.2) 72 (16.9) 0.285 0.594 3.564
0105 12 (5.7) 43 (10.1) 3.415 0.065 0.390
0106 40 (19.0)a 38 (8.9) 13.408 0.0001 <0.001
0107N 12 (5.7) 31 (7.3) 0.545 0.460 2.760
Table 2 MICB allele frequen-
cies in patients with ulcerative
colitis (UC) and healthy controls
(HC) [n (%)]
aOR=2.402; 95%CI,
1.488–3.879
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Discussion
Our study focused on the polymorphism of MIC gene
which has strong linkage disequilibrium with MHC class I
gene. MICA and MICB exclusively encode transcripts and
respond to protein expression among all MIC members,
while the association of MICB exon 2–4 polymorphisms
and soluble MICA (sMICA) expression with the suscepti-
bility of UC has still not been clarified.
In recent studies on MIC genes susceptible to UC,
MICA*007 [23], MICA*00801, and MICA-A6 [36] were
shown to be associated with UC onset in Japan. Previously,
we found that MICA-A5.1/A5.1 homozygous genotype
MICA-A5.1 [27] and MICB-CA18 [28] alleles were
associated with UC in the Chinese Han population. In this
study, we included a limited population in central China
which may not be generalized; however, we found that the
frequency of MICB0106 allele was significantly higher in
the UC group, especially in patients with extensive colitis,
moderate and severe disease, and in those with extraintes-
tinal manifestations. In addition, the frequency of
MICB0106 was significantly higher in the male UC
patients and patients over the age of 40 years than in
healthy controls. These positive associations suggest that
the people carrying MICB0106 allele are at higher risk of
developing UC and might be affected more severely and
more extensively throughout the colon or develop more
extraintestinal manifestations. In terms of UC susceptibility,
males and older people are more affected. We did not
analyze the association of UC with MICB genotype
because of the small size of each subgroup.
So far, very few studies have observed a relationship
between MICB gene polymorphism and UC. Based on
genotyping, we selected several publications [22, 35] from
a number of different ethnic populations. The comparison
of MICB alleles in our study (Hubei Han population,
China) with those in England and Spain showed significant
differences in the distribution of the exon2–4 of MICB
alleles (Chinese vs. English, χ2=50.233, P=0.0001; Chi-
nese vs. Spanish, χ2=13.700, P=0.018). Furthermore,
significant differences in the distribution of the intron 1 of
MICB alleles were also observed between the Chinese and
other populations [28]. These findings suggest that the
differences in ethnic and regional living environment would
influence on the MICB gene distribution. The association of
MICB with UC might be specific to the Chinese population
or even to the Han population in central China.
The neighbors MICA and MICB have big similarities in
both molecular structure and encoding function. The
analysis in available Spanish families indicated that
MICB0106 was part of the B8-DR3-DQ2 haplotype
(HLA-B*0802-MICA-A5.1-MICB0106-DRB1-*0301-
DQA1-*0501-DQB1-*0201). Accordingly, a strong linkage
disequilibrium of MICB0106 with DQ2 (λs=1) and MICA-
A5.1 (λs=0.55) was observed [37]. In our previous study
[27], we also observed that some MICA-MICB haplotypes
occurred at frequencies of strong linkage disequilibrium
(P<0.01). Therefore, we hypothesize that sMICA expres-
sion in serum might also be associated with UC.
By ELISA analysis, we found sMICA are positively
associated with UC compared with healthy controls but not
associated with MICB gene polymorphism. These observa-
tions indicate that sMICA plays a very important role in UC
patients, while it is still not clear whether sMICA protein
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Fig. 2 a sMICA concentration in UC patients and HC.* The mean
sMICA concentration in the serum of 33 UC patients (604.41±
480.43 pg/ml) was significantly higher than that in 32 healthy controls
(175.37±28.31 pg/ml). Z=−6.967, P=0.0001. b sMICA concentration
in three subgroups of UC patients. The sMICA concentration in the
subgroups of MICB0106 carriers, MICA-A5.1 carriers, and non-
MICB0106/MICA-A5.1 carriers was 647.64±518.07 pg/ml, 641.76±
603.73 pg/ml, and 543.32±343.70 pg/ml, respectively. The differ-
ences between sMICA levels among them did not reach statistical
significance (P ¼ 0:487 > 0:05)
Table 3 The difference of MICB distributions in China and western
countries
MICB allele Hubei Han Chinese English Spanish
χ2 – 50.233 13.700
Degrees of freedom – 5 5
P – 0.0001 0.018
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expression is related to the MICB0106 and MICA-A5.1
genotype. The significantly higher MICB0106 gene ex-
pression may not be able to fully affect sMICA protein
expression, which means that it might affect the function of
MIC genes in ways other than genotype or the relatively
small sample we studied. A bias of this study might also be
that the serum samples were not taken at the time point of
diagnosis, so that the rate of disease development may vary
between patients. Therefore, a prospective study to analyze
serum samples procured at the time of diagnosis will help
to clarify whether sMICA can identify risk patients or
optimize patient treatment.
As previously reported, MIC expression is under the
control of heat shock elements and is increased in response
to cellular stress [6] including viral [38] and bacterial
infection [39]. In recent observations, MIC-NKG2D en-
gagement augments both the cytotoxic response of CMV-
infected CD8+αβT cells and TCR-dependent activation of
Vg2Vδ2 T cells by bacterial antigens, which suggest that
this interaction might provide an important costimulatory
signal for cytokine production and cellular proliferation
[22]. sMICA molecules impair the functions of NKG2D+ T
and NK cells, which may facilitate tumor cells to escape
from immunosurveillance [40]. Serum levels of sMICA
have been shown to be of diagnostic significance in
malignant diseases of various origins, including multiple
myeloma [41] and colon adenocarcinoma [34]. sMICA are
elevated and responsible for down-modulation of NKG2D
and other important activating chemokine receptors to
deactivate NK immunity. These immune reactions may
also present in UC disease which confirms our findings.
In conclusion, our study strongly suggests that MICB
gene polymorphism is positively associated with UC in the
Han Chinese in central China; sMICAwas highly expressed
in UC but not associated with the MICB0106 genotype.
Further investigation on the function of MIC genes may be
interesting in future.
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